Molnupiravir is not Ivermectin. >Molnupiravir is a small-molecule ribonucleoside prodrug of N-hydroxycytidine (NHC), which has activity against SARS-CoV-2 and other RNA viruses and a high barrier to development of resistance.12-19 After oral administration of molnupiravir, NHC circulates systemically and is phosphorylated intracellularly to NHC triphosphate. NHC triphosphate is incorporated into viral RNA by viral RNA polymerase and subsequently misdirects the viral polymerase to incorporate either guanosine or adenosine during viral replication. This leads to an accumulation of deleterious errors throughout the viral genome that ultimately render the virus noninfectious and unable to replicate https://www.nejm.org/doi/full/10.1056/NEJMoa2116044 Ivermectin: >Ivermectin is a derivative of a family of macrocyclic lactones, the avermectins , that are produced by the filamentous bacterium Streptomyces avermitilis. Selective hydrogenation of avermectin B\ yields 22-23-dihydroavermectin BJ, which bears the generic name ivermectin. https://www.annualreviews.org/doi/pdf/10.1146/annurev.mi.45.100191.002305 Funnily enough, Merck is the producer for both the new drug Molnupiravir and Ivermectin in the 1970s.